{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:57:48Z","timestamp":1783979868536,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PRAMAN WORKSHOP, AIIMS JODHPUR","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-025-00769-y","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:48:20Z","timestamp":1768546100000},"page":"257-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of ARB-Based Combination Therapies for Treatment of Hypertension: A Systematic Review and Meta-analyses"],"prefix":"10.1007","volume":"33","author":[{"given":"Ranu","family":"Oza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-3060","authenticated-orcid":false,"given":"Pankaj","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimple Jeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil Dhanesh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharamveer","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Prabha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaykaran","family":"Charan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"769_CR1","unstructured":"World Health Organization. Hypertension [Internet]. Geneva: World Health Organization; 2025 [cited 2025 Mar 18]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension"},{"key":"769_CR2","unstructured":"World Health Organization. Cardiovascular diseases (CVDs) [Internet]. Geneva: World Health Organization. 2025 [cited 2025 Mar 18]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"issue":"10022","key":"769_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure Lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(15)01225-8.","journal-title":"Lancet"},{"issue":"7","key":"769_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamacardio.2017.1424","volume":"2","author":"JD Bundy","year":"2017","unstructured":"Bundy JD, Li C, Stuchlik P, Bu X, Kelly TN, Mills KT, He H, Chen J, Whelton PK, He J. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2(7):775\u201381. https:\/\/doi.org\/10.1001\/jamacardio.2017.1424.","journal-title":"JAMA Cardiol"},{"key":"769_CR5","doi-asserted-by":"publisher","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison-Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. Hypertension. 2018;71(6):1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000066.","DOI":"10.1161\/HYP.0000000000000066"},{"issue":"1","key":"769_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2125.2012.04471.x","volume":"75","author":"CH Manisty","year":"2013","unstructured":"Manisty CH, Hughes AD. Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. Br J Clin Pharmacol. 2013;75(1):79\u201392. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04471.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"769_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ajh\/5.2.95","volume":"5","author":"B Dahl\u00f6f","year":"1992","unstructured":"Dahl\u00f6f B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5(2):95\u2013110. https:\/\/doi.org\/10.1093\/ajh\/5.2.95.","journal-title":"Am J Hypertens"},{"issue":"19","key":"769_CR8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/jama.1996.03530430057032","volume":"275","author":"RE Schmieder","year":"1996","unstructured":"Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA. 1996;275(19):1507\u201313. https:\/\/doi.org\/10.1001\/jama.1996.03530430057032.","journal-title":"JAMA"},{"issue":"1","key":"769_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9343(02)01416-0","volume":"115","author":"AU Klingbeil","year":"2003","unstructured":"Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med. 2003;115(1):41\u20136. https:\/\/doi.org\/10.1016\/S0002-9343(02)01416-0.","journal-title":"Am J Med"},{"issue":"5","key":"769_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.138513","volume":"54","author":"RH Fagard","year":"2009","unstructured":"Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension. 2009;54(5):1084\u201391. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.138513.","journal-title":"Hypertension"},{"issue":"23","key":"769_CR11","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/eurheartj\/ehz146","volume":"40","author":"J van der Leeuw","year":"2019","unstructured":"van der Leeuw J, van Dalen JW, Stricker BH, van den Meiracker AH, Verlinden VJA, Ikram MA, Mattace-Raso FUS, Franco OH, de Maat MPM, Launer LJ, Sedaghat S. Effects of renin-angiotensin-aldosterone system inhibitors on left ventricular mass: a meta-analysis of randomized clinical trials. Eur Heart J. 2019;40(23):1805\u201314. https:\/\/doi.org\/10.1093\/eurheartj\/ehz146.","journal-title":"Eur Heart J"},{"issue":"3","key":"769_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting\u2013enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145\u201353. https:\/\/doi.org\/10.1056\/NEJM200001203420301.","journal-title":"N Engl J Med"},{"issue":"9311","key":"769_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahl\u00f6f","year":"2002","unstructured":"Dahl\u00f6f B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against Atenolol. Lancet. 2002;359(9311):995\u20131003. https:\/\/doi.org\/10.1016\/S0140-6736(02)08089-3.","journal-title":"Lancet"},{"issue":"9489","key":"769_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O\u2019Brien E, Ostergren J, for the ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding Perindopril as required versus Atenolol adding Bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes Trial\u2013Blood pressure Lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895\u2013906. https:\/\/doi.org\/10.1016\/S0140-6736(05)67185-1.","journal-title":"Lancet"},{"issue":"23","key":"769_CR15","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, Dahl\u00f6f B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ. For the ACCOMPLISH trial Investigators. Benazepril plus amlodipine or Hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359(23):2417\u201328. https:\/\/doi.org\/10.1056\/NEJMoa0806182.","journal-title":"N Engl J Med"},{"issue":"10008","key":"769_CR16","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","volume":"386","author":"B Williams","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, Webb DJ, Sever P, McInnes G, Ford I, Cruickshank JK, Caulfield MJ, Salsbury J, Mackenzie I, Padmanabhan S, Brown MJ, for the British Hypertension Society\u2019s PATHWAY Studies Group. Spironolactone versus placebo, bisoprolol, and Doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015;386(10008):2059\u201368. https:\/\/doi.org\/10.1016\/S0140-6736(15)00257-3.","journal-title":"Lancet"},{"issue":"2","key":"769_CR17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.114.04644","volume":"65","author":"A Zanchetti","year":"2015","unstructured":"Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of combination therapy vs monotherapy for hypertension: a meta-analysis. Hypertension. 2015;65(2):286\u201393. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04644.","journal-title":"Hypertension"},{"issue":"10","key":"769_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1097\/HJH.0000000000001036","volume":"34","author":"C Thomopoulos","year":"2016","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure Lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: systematic review and meta-analyses. J Hypertens. 2016;34(10):1921\u201332. https:\/\/doi.org\/10.1097\/HJH.0000000000001036.","journal-title":"J Hypertens"},{"issue":"5","key":"769_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/HJH.0000000000001276","volume":"35","author":"C Thomopoulos","year":"2017","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure Lowering on outcome incidence in hypertension: 10. Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. J Hypertens. 2017;35(5):922\u201344. https:\/\/doi.org\/10.1097\/HJH.0000000000001276.","journal-title":"J Hypertens"},{"issue":"12","key":"769_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1097\/HJH.0000000000001512","volume":"35","author":"C Thomopoulos","year":"2017","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure Lowering on outcome incidence in hypertension: 11. Effects in elderly patients; overview and meta-analyses of randomized trials. J Hypertens. 2017;35(12):2313\u201324. https:\/\/doi.org\/10.1097\/HJH.0000000000001512.","journal-title":"J Hypertens"},{"key":"769_CR21","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure Lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomized trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. https:\/\/doi.org\/10.1136\/bmj.b1665.","journal-title":"BMJ"},{"issue":"9395","key":"769_CR22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","volume":"362","author":"F Turnbull","year":"2003","unstructured":"Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S. For the blood pressure Lowering treatment trialists\u2019 Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362(9395):1527\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(03)14739-3.","journal-title":"Lancet"},{"issue":"9246","key":"769_CR23","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","volume":"356","author":"B Neal","year":"2000","unstructured":"Neal B, MacMahon S, Chapman N, for the Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood pressure Lowering treatment trialists\u2019 collaboration. Lancet. 2000;356(9246):1955\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(00)03307-9.","journal-title":"Lancet"},{"issue":"12","key":"769_CR24","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1001\/archinte.165.12.1410","volume":"165","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2005","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005;165(12):1410\u20139. https:\/\/doi.org\/10.1001\/archinte.165.12.1410.","journal-title":"Arch Intern Med"},{"issue":"7653","key":"769_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","volume":"336","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2008","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomized trials. BMJ. 2008;336(7653):1121\u20133. https:\/\/doi.org\/10.1136\/bmj.39548.738368.BE.","journal-title":"BMJ"},{"issue":"9395","key":"769_CR26","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","volume":"362","author":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration","year":"2003","unstructured":"Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet. 2003;362(9395):1527\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(03)14739-3.","journal-title":"Lancet"},{"issue":"8","key":"769_CR27","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1097\/HJH.0000000000001767","volume":"36","author":"C Thomopoulos","year":"2018","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure Lowering treatment on cardiovascular outcomes and mortality: 13 \u2013 Effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analyses. J Hypertens. 2018;36(8):1622\u201335. https:\/\/doi.org\/10.1097\/HJH.0000000000001767.","journal-title":"J Hypertens"},{"issue":"1","key":"769_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/HJH.0000000000001156","volume":"35","author":"C Thomopoulos","year":"2017","unstructured":"Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure Lowering on outcome incidence in hypertension: 12 \u2013 Effects in patients with prior cerebrovascular disease: overview and meta-analyses of randomized trials. J Hypertens. 2017;35(1):23\u201344. https:\/\/doi.org\/10.1097\/HJH.0000000000001156.","journal-title":"J Hypertens"},{"issue":"33","key":"769_CR29","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, for the ESC Scientific Document Group. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J"},{"issue":"11","key":"769_CR30","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension: JACC health promotion series. J Am Coll Cardiol. 2018;72(11):1278\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.008.","journal-title":"J Am Coll Cardiol"}],"container-title":["High Blood Pressure &amp; Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-025-00769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-025-00769-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-025-00769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:42:53Z","timestamp":1780119773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-025-00769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1007\/s40292-025-00769-y","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of Interest"}}]}}